The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA.
Nasonov EL, Mazurov VI, Lila AM, Dubinina TV, Gaidukova IZ, Lapshina SA, Klimenko AA, Somov DV, Lukyanov SA, Chudakov DM, Zvyagin IV, Britanova OV, Korolev MA, Abdulganieva DI, Krechikova DG, Kastanayan AA, Eliseeva LV, Samigullina RR, Povarova TV, Antipova OV, Smakotina SA, Soboleva VN, Nesmeyanova OB, Plaksina TV, Soroka NF, Vinogradova IB, Rebrov AP, Kropotina TV, Maslyansky AL, Zinkina-Orikhan AV, Linkova YN, Pukhtinskaya PS, Morozova MA, Vinderskaya GA.
Nasonov EL, et al. Among authors: plaksina tv.
Dokl Biochem Biophys. 2025 Jun;522(1):387-403. doi: 10.1134/S1607672925700140. Epub 2025 May 11.
Dokl Biochem Biophys. 2025.
PMID: 40353961
Clinical Trial.